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Abstract
Joubert syndrome is a clinically and genetically heterogeneous ciliopathy characterized by a typical cerebellar and
brainstem malformation (the “molar tooth sign”), and variable multiorgan involvement. To date, 24 genes have
been found mutated in Joubert syndrome, of which 13 also cause Meckel syndrome, a lethal ciliopathy with kidney,
liver and skeletal involvement. Here we describe four patients with mild Joubert phenotypes who carry pathogenic
mutations in either MKS1 or B9D1, two genes previously implicated only in Meckel syndrome.
Keywords: Joubert syndrome, Meckel syndrome, Ciliopathies, Primary cilium, MKS1, B9D1, Genotype-phenotype
correlates
Findings
Background
Joubert syndrome (JS, MIM213300) is a congenital dis-
order diagnosed by the presence of a peculiar midbrain-
hindbrain malformation (the “molar tooth sign”, MTS),
that consists of cerebellar vermian hypodysplasia, thick-
ened mal-oriented superior cerebellar peduncles, and a
deepened interpeduncular fossa. The typical neurological
features of pure JS include hypotonia, ataxia, psycho-
motor delay, abnormal ocular movements, intellectual
impairment of variable degree, and often breathing ab-
normalities. This phenotype may be complicated by de-
fects of the kidneys (nephronophthisis), eyes (retinal
dystrophy or colobomas), liver (congenital fibrosis), ske-
leton (mainly polydactyly), and orofacial defects (cleft lip
and/or palate, tongue hamartomas), resulting in wide
clinical variability [1].
JS is recessively inherited and genetically heterogeneous,
with 24 known genes that overall account for about half
cases. All genes encode for proteins of the primary cilium,
and indeed there is clinical and genetic overlap with other
ciliopathies. In particular, JS shares 13 genes with Meckel
syndrome (MS, MIM249000), a lethal condition character-
ized by cystic kidneys, bile duct proliferation of the liver,
encephalocele and polydactyly. Other malformations fre-
quently include cleft lip and palate, bowing of long bones
and other skeletal defects, and situs inversus [2].
Identification of MKS1 and B9D1 mutations in JS patients
As part of a large screening of ciliopathy genes in 260 JS
patients, we identified novel pathogenic mutations in two
genes not previously implicated in this condition.
Two patients carried mutations in the MKS1 gene
[GenBank:NG_013032.1], a 44-year-old man with JS and
retinal dystrophy (COR340), and a 2-year-old child with
a pure JS phenotype (COR413). Mutations in the B9D1
gene [GenBank:NG_031885.1] were identified in two
other patients, a 9-year-old boy (COR363) and a 7-year-
old girl (COR346), both presenting with pure JS. All
identified mutations were inherited from heterozygous
healthy parents, were not reported in public databases,
and affected highly conserved residues (Figure 1). Missense
mutations were predicted as pathogenic by prediction web
tools. Clinical features of the four patients, compared with
the phenotypes of the six JS subgroups [1], are summarized
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in Table 1. Individual case reports and details on genetic
analysis are described in the Additional file 1.
Discussion
Pathogenic mutations in MKS1 and B9D1 have been re-
ported only in MS fetuses. MKS1 is mutated in about
7-14% of MS patients, with increased frequency in
northern European countries due to a founder mutation
[3-7]. Several studies have highlighted that mutations in
MKS1 are associated with a particularly severe MS
phenotype, with high occurrence of polydactyly, bone
dysplasia, encephalocele and other central nervous sys-
tem anomalies [4-6]. To date, B9D1 was found mutated
only in one MS fetus with cystic dysplastic kidneys, en-
cephalocele, shortened limbs and ambiguous genitalia
[8]. Conversely, the four JS patients described here all
had a relatively mild presentation characterized by a
pure neurological phenotype, with the exception of retinal
dystrophy in patient COR340. The degree of intellectual
impairment was variable, and patient COR413 even pre-
sented with normal intellectual abilities, a rare occurrence
in JS [9]. None of the patients showed involvement of the
organs that are typically affected in MS, namely the kid-
neys, liver and skeleton, although a future renal disease
can be safely excluded only in the adult patient (COR340).
This wide phenotypic variability associated with mu-
tations in the same genes remains an intriguing open
question. Genotype-phenotype correlates have been pro-
posed for some genes (such as RPGRIP1L, TMEM67,
CCD2D2A and TCTN3), with biallelic null mutations
causative of lethal phenotypes, and at least one hypo-
morphic missense mutation found in JS [10-13]. This
could also hold true for MKS1 and B9D1. In fact, most
MS fetuses are known to carry two null mutations in these
genes [4,8]; conversely, three of our JS patients have at
least one mutation not resulting in protein truncation,
and the fourth is homozygous for a splice-site muta-
tion involving the penultimate exon of MKS1, whose
Figure 1 Brain magnetic resonance imaging and characterization of mutations of the four patients. A) Parasagittal (left) and axial (right)
magnetic resonance imaging sections showing thickened and elongated superior cerebellar peduncles (arrows), and the molar tooth sign
(circles). Parasagittal images are not available for patient COR340. B) Electropherograms showing the identified mutations; C) conservation of
affected amino acid residues among orthologues (for missense mutations or single amino acid deletions), or prediction of aberrant splicing (for
splice-site mutations).
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pathogenetic impact on the protein remains to be deter-
mined (See Additional file 1) (Figure 1). Interestingly, a
previous study identified two hypomorphic mutations in
theMKS1 gene (a missense change and a single aminoacid
deletion) in a 2-year-old Turkish patient with Bardet-
Biedl syndrome, another non-lethal ciliopathy partly over-
lapping with JS, supporting this hypothesis [14]. Yet, these
genotype-phenotype correlates are unlikely to fully explain
the extreme phenotypic variability of these allelic cilio-
pathies, and other mechanisms, such as the presence of
modifier variants in other genes, need to be explored.
MKS1, B9D1 and B9D2 proteins are known to interact
physically [15], and are main components of the “B9” or
“Tectonic” complex residing at the ciliary transition zone,
that includes many other proteins mutated in JS and/or
MS [16]. In our large JS cohort, MKS1 and B9D1 muta-
tions each account for less than 1% cases. We failed to
identify mutations in B9D2, but we cannot exclude that
this gene may also be rarely mutated in JS.
In conclusion, we expand the genetic basis of JS to in-
clude MKS1 and B9D1, delineate genotype-phenotype
correlates, and further outline JS and MS as the two
ends of a common spectrum. These findings have impli-
cations for genetic testing and counselling of JS patients
and their families.
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Table 1 Phenotypic comparison of the four patients presented here with JS clinical subgroups
Present cases JS clinical subgroups (as in ref 1)
COR340
(MKS1)
COR413
(MKS1)
COR363
(B9D1)
COR346
(B9D1)
Pure With
retina
With
kidney
With retina
& kidney
With
liver
OFD-VI
CNS:
- hypotonia/ataxia + + + + + + + + + +
- breathing abn. - - - - ± ± ± ± ± ±
- develop. delay + + + + + + + + + +
- ID + + + - ± + + + + ±
- oculomotor abn.* + + + + ± ± ± ± ± ±
Ocular:
- retinopathy + - - - - + - + - -
- coloboma - - - - ± rare rare rare ± rare
Renal: - - - - - - + + ± rare
Hepatic: - - - - - - - rare + -
Other features:
- polydactyly - - - - ± rare rare rare rare ±
- orofacial features - - - - - - - - - ±
- dysmorphisms + - + + ± ± ± ± ± ±
Neuroimaging:
- MTS + + + + + + + + + +
- other CNS defects** - - - - rare rare rare rare rare ±
Legend: For the six JS subgroups, the meaning of symbols is as follows: “+”: mandatory feature; “±”: feature that could be part of the phenotype but is not
mandatory; “rare”: feature that was only rarely described in the subgroup; “-“: never described to date. *mainly oculomotor apraxia and/or nistagmus; **mostly
including corpus callosum hypoplasia, encephalocele, neuronal migration defects (e.g. polymicrogyria), hypothalamic hamartoma (in OFD-VI).
Abbreviations: abn abnormalities, CNS central nervous system, develop developmental, ID intellectual disability of variable severity, MTS molar tooth sign.
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